ストックスクリーナーアプリを入手
1.43
0.69%
-0.01
前日終値:
$1.44
開ける：
$1.46
24時間の取引高:
17,371
Relative Volume:
0.10
時価総額：
$9.88M
収益：
$3.19M
当期純損益:
$-10.42M
株価収益率:
-0.0403
EPS:
-35.4757
ネットキャッシュフロー:
$-10.65M
1週間 パフォーマンス:
-4.67%
1か月 パフォーマンス:
-19.21%
6か月 パフォーマンス:
-42.57%
1年 パフォーマンス:
+22.22%
1日の値動き範囲:
$1.41
$1.4645
1週間の範囲:
$1.41
$1.6498
52週間の値動き範囲:
$1.00
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
INBS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.43 | 11.30M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
130.84 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.82 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.70 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.61 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.72 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - GlobeNewswire
Intelligent Bio Solutions CEO Reveals Growth Strategy at Exclusive Sidoti Conference - Stock Titan
Intelligent Bio Solutions shares rise 4.52% after-hours after reporting strong Q4 revenue growth and U.S. FDA 510(k) clearance progress. - AInvest
Intelligent Bio Solutions reports double-digit revenue growth in Q4 and FY23. - AInvest
Intelligent Bio Solutions Inc. shares fall 1.28% intraday after reporting preliminary fiscal fourth quarter revenue growth of 16%. - AInvest
Intelligent Bio Solutions: A High-Conviction Play on Recurring Revenue and U.S. Market Breakout Potential - AInvest
Intelligent Bio Reports Strong Q4 Revenue Growth and Operational Momentum - TradingView
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - The Manila Times
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Qu - GuruFocus
Intelligent Bio Solutions Expects 16% YoY Growth in Q4 Revenue - AInvest
INBS Expects 16% Q4 Sequential, YoY Revenue Growth, Advances FDA Clearance - AInvest
Intelligent Bio Solutions Achieves 16% Revenue Jump as FDA Application for Revolutionary Opiate Test Advances - Stock Titan
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4 - Yahoo Finance
Intelligent Bio Solutions shares rise 2.56% after-hours after strengthening FDA 510(k) package with new cybersecurity and performance data. - AInvest
Intelligent Bio Solutions submits FDA response for drug screening tech By Investing.com - Investing.com Canada
Intelligent Bio Solutions submits FDA response for drug screening tech - Investing.com
Intelligent Bio Solutions Submits Key FDA Information - TipRanks
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch - MarketScreener
INBS submits new data to FDA for 510(k) clearance of fingerprint drug screening tech. - AInvest
Intelligent Bio Solutions Strengthens FDA 510(k) Package with Ne - GuruFocus
Intelligent Bio Solutions submits Additional Information to FDA for 510(k) clearance. - AInvest
Massive FDA Data Package: Bio Solutions' Drug Test Aims for Quick Approval After 10,000 Hours of Testing - Stock Titan
Intelligent Bio Solutions Inc. shares rise 2.04% intraday after Eni and LG Chem launch sustainable fuel plant in South Korea. - AInvest
What drives Intelligent Bio Solutions Inc. stock priceFree Technical Analysis Support - Jammu Links News
When is Intelligent Bio Solutions Inc. stock expected to show significant growthInvest like a pro with expert recommendations - Jammu Links News
What catalysts could drive Intelligent Bio Solutions Inc. stock higher in 2025Invest smarter with actionable stock recommendations - Jammu Links News
What institutional investors are buying Intelligent Bio Solutions Inc. stockGet real-time alerts on high-potential stocks - Jammu Links News
Why Intelligent Bio Solutions Inc. stock attracts strong analyst attentionLow Risk Swing Trade Opportunities Identified - beatles.ru
Should I hold or sell Intelligent Bio Solutions Inc. stock in 2025Find market-beating stocks for your portfolio - Jammu Links News
Does Intelligent Bio Solutions Inc. stock perform well during market downturnsUnlock expert trading strategies for growth - Jammu Links News
What are the latest earnings results for Intelligent Bio Solutions Inc.Unlock your trading potential today - Jammu Links News
How does Intelligent Bio Solutions Inc. compare to its industry peersAccelerated investment success - Jammu Links News
What are analysts’ price targets for Intelligent Bio Solutions Inc. in the next 12 monthsExplosive returns - Jammu Links News
Why is Intelligent Bio Solutions Inc. stock attracting strong analyst attentionGet exclusive market insights for better trading - Jammu Links News
What is the risk reward ratio of investing in Intelligent Bio Solutions Inc. stockRapidly expanding wealth - Jammu Links News
How volatile is Intelligent Bio Solutions Inc. stock compared to the marketFinancial News Target Finder For Smart Trading - jammulinksnews.com
Combining price and volume data for Intelligent Bio Solutions Inc.Free Sector Based Breakout Stock Forecast - Newser
Intelligent Bio Solutions Inc. shares fall 6.96% intraday amid Trump's America First biodiesel policy concerns. - AInvest
What makes Intelligent Bio Solutions Inc. stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
What is the dividend policy of Intelligent Bio Solutions Inc. stockExpert Picks Data Feed For Consistent Profits - Jammu Links News
Intelligent Bio Solutions ($INBS) Forms Global Distribution Agreement with SMARTOX - Podomatic
Intelligent Bio Solutions Secures Major Contract To Deploy Drug Screening System Across London's Public Transport Network - 富途牛牛
Intelligent Bio Solutions Inc. Secures Major Drug Testing Tender with London Transport Operator - MarketScreener
Intelligent Bio Solutions Inc. Price Holds Above Key Fib LevelProfit Focused Stock Screener Results Released - metal.it
London transport operator selects INBS for drug screening system By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator - The Manila Times
Intelligent Bio Solutions Secures Major London Transport Contract for Drug Testing System - AInvest
Intelligent Bio Solutions Lands Massive Drug Testing Deal: 4,400 Staff Across 14 London Transport Sites - Stock Titan
Should investors worry about INBS's earnings trend? - AInvest
How did INBS's revenue streams evolve in Q2 2025 compared to previous quarters? - AInvest
What caused INBS's earnings surprises in 2024? - AInvest
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.59%
大文字化:
|
ボリューム (24 時間):